<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
73536-500-01
</NDCCode>
<PackageDescription>
1 SYRINGE, GLASS in 1 CARTON (73536-500-01) / 1 mL in 1 SYRINGE, GLASS
</PackageDescription>
<NDC11Code>
73536-0500-01
</NDC11Code>
<ProductNDC>
73536-500
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Besremi
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Ropeginterferon Alfa-2b
</NonProprietaryName>
<DosageFormName>
INJECTION
</DosageFormName>
<RouteName>
SUBCUTANEOUS
</RouteName>
<StartMarketingDate>
20211112
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA761166
</ApplicationNumber>
<LabelerName>
PharmaEssentia USA
</LabelerName>
<SubstanceName>
ROPEGINTERFERON ALFA-2B
</SubstanceName>
<StrengthNumber>
500
</StrengthNumber>
<StrengthUnit>
ug/mL
</StrengthUnit>
<Pharm_Classes>
Interferon alfa-2b [CS], Interferon alfa-2b [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-12-17
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20211112
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>